Generate a tailored SOP for Dr. Michael Digiovanna. Improve your application with a focused, well-structured draft.
Michael DiGiovanna, MD, PhD, is a Professor of Medicine (Oncology) and Pharmacology at Yale University. He graduated from Cornell University in 1984 with a B.A. double major in Biochemistry and Music and obtained his MD and PhD in Pharmacology from Yale University in 1990. He completed his post-graduate training at Yale, including an internship and residency in Internal Medicine, along with a clinical fellowship in Medical Oncology. Dr. DiGiovanna specializes in breast cancer treatment and conducts clinical and laboratory-based research. His research focuses on signal transduction, particularly the interaction of HER2 signaling with estrogen receptor signaling, and the impact of growth factor receptor tyrosine kinases on clinical outcomes. He has significantly contributed to understanding targeted therapies in cancer treatment and has received multiple awards for his work, including the American Cancer Society Research Scholar Grant and the Women's Health Investigator Award. Dr. DiGiovanna also holds leadership roles in education at the Yale School of Medicine, including serving as Co-Director of the Pre-Clerkship Curriculum and Thread Leader in Pharmacology.
Administered via the Graduate School of Arts and Sciences (GSAS). GRE General is optional for PhD.